Non-Human Primate (NHP) Tissue Distribution & Mass Balance In Vivo Pharmacokinetic (PK) Service

Are you currently facing long drug development cycles, challenges in predicting human responses from preclinical data, or complex clinical trial design? Our Non-Human Primate Tissue Distribution & Mass Balance In Vivo PK Studies help you accelerate the drug discovery process and obtain critical data for successful clinical trials. Utilizing advanced in vivo study protocols and robust bioanalytical platforms, we provide a precise and comprehensive understanding of your drug's behavior.

Overview of NHP PK Services

What Our Service Is

Creative Biolabs' Non-Human Primate Tissue Distribution & Mass Balance In Vivo PK Studies are designed to provide a comprehensive understanding of a drug's ADME profile. These studies are essential for determining how a compound is distributed throughout the body, its metabolic fate, and how it is ultimately eliminated. Our services are critical for:

• Predicting first-in-human (FIH) dosing strategies for small molecules and biologics.
• Validating the drug's intended targeting and understanding potential off-target accumulation in various organs and tissues.
• Assessing the safety profile by identifying organs where the drug or its metabolites may accumulate at toxic levels.

Why Choose Us?

NHP are a crucial model in drug development due to their high genetic and physiological similarity to humans. For many biologics, such as monoclonal antibodies, NHPs are often the only relevant preclinical species for PK/PD evaluation, as the drug's target may not be present in other animal models. Choosing Creative Biolabs means you benefit from highly predictive data that de-risks your program and provides a clear pathway to clinical trials, avoiding the unpredictable outcomes that can arise from less relevant animal models.

Fig.1 PK results of a BsAb in rats, and monkeys.¹

Key Benefits of Our Service

Our Non-Human Primate Tissue Distribution & Mass Balance In Vivo PK Studies offer several key advantages that can significantly accelerate your drug development pipeline:

• Expedited Timelines: With established protocols and efficient workflows, we provide a fast turnaround on critical data, allowing you to make informed decisions and move your project forward without unnecessary delays.
• Unrivaled NHP Resources: We have access to an extensive population of NHPs, including Cynomolgus, Rhesus, Marmoset, and African Green Monkey, ensuring that your studies can be initiated and completed efficiently, even for complex or large-scale programs.
• Customized Study Design: Our team works closely with you to design a study that is precisely tailored to your specific project goals and the unique characteristics of your compound. This ensures that the data you receive is relevant and actionable.
• Comprehensive Reporting: We provide detailed, in-depth reports that go beyond raw data. Our analyses include full PK parameter calculations, graphical representations of concentration-time curves, and expert scientific interpretations, giving you a complete picture of your drug's in vivo behavior.

How Creative Biolabs' Service Can Assist Your Project?

Our services provide critical insights into your compound's biodistribution and elimination, helping you to optimize dosing, understand safety profiles, and confidently transition from preclinical to clinical development. We solve the challenge of accurately predicting human responses by providing high-quality, in vivo data from the most relevant animal model.

Key Deliverables

Upon completion of your study, you will receive a comprehensive data package, including:

• A final lab report detailing all methods, results, and conclusions.
• Raw data files from all bioanalytical assays.
• Tables of PK/TK parameters and statistical analysis.
• Graphical representations of concentration-time curves for visual analysis.
• Summary of findings and expert conclusions.

Capabilities & Partnerships

Service-Specific Data

• Annual Sample Size: 50000+
• Typical Turnaround Time: 8-12 weeks
• Method Validation Pass Rate: 95%+

Our Valued Partners

Frequently Asked Questions

Contact Us

At Creative Biolabs, we provide the highest quality Non-Human Primate Tissue Distribution & Mass Balance In Vivo PK Studies to meet the unique needs of your drug development program. Our expert team and state-of-the-art facilities ensure that you receive the precise, reliable data you need to make confident decisions. To learn more about our services or to discuss your specific project needs, please contact us today.